Identification of Target Candidates for Pancreatic Adenocarcinoma Immunotherapy
Time: 9:30 am
day: Day Two
Details:
- Miltenyi Biotec presents the MACSima Ultra-high content imaging platform
- Learn how MICS technology enables you to visualize hundreds of markers from
fixed tissue to lift your sample analysis to the next level - See a comprehensive workflow for the identification of new target candidates
